GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
K

Kuvatris Therapeutics PXMD · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

0.00%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Kuvatris Therapeutics — daily PXMD Delayed
Market value
$88,382
Last close × shares
Volume
300
Shares, 9 Nov 2026

About Kuvatris Therapeutics

Its shares trade under the ticker PXMD. It has been listed since 19 August 2022.

PaxMedica Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in Tarrytown, New York. The company went IPO on 2022-08-19. PaxMedica, Inc. is a clinical-stage biopharmaceutical company. The firm is focusing on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms, ranging from neurodevelopmental disorders, including autism spectrum disorder (ASD), to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), a debilitating physical and cognitive disorder believed to be viral in origin and with rising incidence globally due to the long-term effects of SARS-CoV-2 (COVID-19). Its PAX-101, an intravenous formulation of suramin, in the treatment of ASD and the advancement of the clinical understanding of using that agent against other disorders such as ME/CFS and Long COVID-19 Syndrome (LCS), a clinical diagnosis in individuals who have been previously infected with COVID-19.

Figures and description from our data supplier, not checked against the company's own report.

More about Kuvatris Therapeutics →

Latest on Kuvatris Therapeutics

Our reporting

We have not reported on Kuvatris Therapeutics yet.

Next results

2 Dec 2026

Due on 2 Dec 2026. Analysts expect earnings of -0.88 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Kuvatris Therapeutics's ticker?

Kuvatris Therapeutics trades as PXMD on its US listing, under ISIN US70424C2035.

What was Kuvatris Therapeutics's last closing price?

0.00 on 9 Nov 2026. The figure is in USD and is never converted.

When does Kuvatris Therapeutics next report results?

Results are expected on 2 Dec 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.